Ali Alaa M, Hill Harriet J, Elkhouly Gehad E, Bakkar Marwa Reda, Raya Nermeen R, Stamataki Zania, Abo-Zeid Yasmin
Department of Pathology, Faculty of Veterinary Medicine, Cairo University, Giza 12211, Egypt.
Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK.
Antibiotics (Basel). 2022 Nov 4;11(11):1556. doi: 10.3390/antibiotics11111556.
Hand hygiene is considered to be the key factor in controlling and preventing infection, either in hospital care settings or in the community. Alcohol-based hand sanitizers are commonly used due to their rapid action and broad spectrum of microbicidal activity, offering protection against bacteria and viruses. However, their frequent administration during COVID-19 pandemic was associated with serious hazards, such as skin toxicity, including irritation, skin dermatitis, skin dryness or cracking, along with peeling redness or itching, with the higher possibility of getting infections. Thus, there is a need to find alternative and novel approaches for hand sanitation. In our previous publications, we reported that rhamnolipids nano-micelles had a comparable antibacterial activity to alcohol-based hand sanitizer and a lower cytotoxicity against human dermal fibroblast cells. In the current study, we investigated the antiviral activity of rhamnolipids nano-micelles against SARS-CoV-2. There was no cytotoxic effect on Vero cells noted at the tested concentrations of rhamnolipids nano-micelles. The rhamnolipids nano-micelles solution at 20, 78, and 312 µg/mL all demonstrated a significant (p < 0.05) decrease of virus infectivity compared to the virus only and the blank vehicle sample. In addition, an acute irritation test was performed on rabbits to further ascertain the biosafety of rhamnolipids nano-micelles. In the eye and skin irritation tests, no degree of irritation was recorded after topical application of rhamnolipids nano-micelles. In addition, histopathological, biomarker, and hematological analyses from animals treated with rhamnolipids nano-micelles were identical to those recorded for untreated animal. From the above, we can conclude that rhamnolipids nano-micelles are a good candidate to be used as a hand sanitizer instead of alcohol-based hand sanitizers. However, they must still be tested in the future among healthcare workers (HCW) in a health care setting to ascertain their antimicrobial efficacy and safety compared to alcohol-based hand sanitizers.
手部卫生被认为是控制和预防感染的关键因素,无论是在医院护理环境还是社区中。基于酒精的洗手液因其快速起效和广泛的杀菌活性而被广泛使用,可提供针对细菌和病毒的防护。然而,在新冠疫情期间频繁使用它们会带来严重危害,如皮肤毒性,包括刺激、皮肤炎、皮肤干燥或开裂,以及脱皮、发红或瘙痒,感染风险更高。因此,需要寻找替代的新型手部清洁方法。在我们之前的出版物中,我们报道了鼠李糖脂纳米胶束具有与基于酒精的洗手液相当的抗菌活性,并且对人皮肤成纤维细胞的细胞毒性较低。在当前研究中,我们研究了鼠李糖脂纳米胶束对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的抗病毒活性。在所测试的鼠李糖脂纳米胶束浓度下,未观察到对非洲绿猴肾细胞(Vero细胞)的细胞毒性作用。与仅含病毒和空白载体样品相比,浓度为20、78和312μg/mL的鼠李糖脂纳米胶束溶液均显示出病毒感染性显著降低(p<0.05)。此外,对兔子进行了急性刺激试验,以进一步确定鼠李糖脂纳米胶束的生物安全性。在眼和皮肤刺激试验中,局部应用鼠李糖脂纳米胶束后未记录到刺激程度。此外,用鼠李糖脂纳米胶束处理的动物的组织病理学、生物标志物和血液学分析与未处理动物记录的结果相同。综上所述,我们可以得出结论,鼠李糖脂纳米胶束是替代基于酒精的洗手液用作手部消毒剂的良好候选物。然而,未来仍必须在医疗环境中的医护人员中进行测试,以确定其与基于酒精的洗手液相比的抗菌效果和安全性。